OTC · THCT
THC Therapeutics, Inc.
$0.00$0.00 (0.0%)
THC Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.3% below the high.
Loading market information…
OTC · DGEN · USD
Stock price, dividends
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Deltagen Inc.’s forward annual dividend is $0.10 per share, paid semi-annual. The forward yield is 100,000.0% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
THE COMPANY BEHIND THE TICKER
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 01:18 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.00$0.00 (0.0%)
THC Therapeutics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.3% below the high.
$0.00$0.00 (0.0%)
Net Medical Xpress Solutions, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.14% below the high.
$0.00$0.00 (0.0%)
Quick-Med Technologies, Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.5% below the high.
$0.00$0.00 (0.0%)
Remedent, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
WellQuest Medical & Wellness Corporation’s quoted price sits in the lower half of its reported 52-week range, 93.55% below the high.
$0.00$0.00 (0.0%)
UpHealth, Inc.’s quoted price sits in the lower half of its reported 52-week range, 97.0% below the high.
$0.00$0.00 (0.0%)
Cyclo3pss Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Nemaura Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.0% below the high.
